Market Place
Sourcing Support
All News #Library
Quality
Delhi HC Restores Ban On 2 Diabetes FDCs
14 Jan 2026 //
ECONOMICTIMES
USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plant
10 Dec 2023 //
ECONOMIC TIMES
FDA put Intas plant on import alert, warning letter shows
29 Nov 2023 //
FIERCE PHARMA
USFDA issues warning letter to Intas Pharma for Sanand plant
06 Aug 2023 //
ECONOMIC TIMES
FDA slams Intas, Ipca over manufacturing shortfalls at 3 plants
07 Jul 2023 //
FIERCE PHARMA
India`s Intas gets more bad news from FDA with import alert
05 Jun 2023 //
FIERCE PHARMA
Intas Pharma — USFDA issues Form-483 with 11 observations for Gujarat unit
11 Jan 2023 //
CNBCTV18
NPPA`s drug overcharging penalty at a record high
11 Mar 2017 //
BUSINESS STANDARD
Top pharma cos overcharging, NPPA lists 634 drugs for breaching price cap
27 Feb 2017 //
BUSINESS STANDARD
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.